Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for TrueBlue (TBI) over the last 17 years, with Q3 2025 value amounting to $3.4 million.

  • TrueBlue's Gains from Investment Securities fell 1322.36% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 771.65%. This contributed to the annual value of $15.3 million for FY2024, which is 336.1% down from last year.
  • Per TrueBlue's latest filing, its Gains from Investment Securities stood at $3.4 million for Q3 2025, which was down 1322.36% from $3.7 million recorded in Q2 2025.
  • TrueBlue's 5-year Gains from Investment Securities high stood at $4.3 million for Q2 2022, and its period low was $3.4 million during Q3 2025.
  • Moreover, its 5-year median value for Gains from Investment Securities was $4.0 million (2023), whereas its average is $3.9 million.
  • The largest annual percentage gain for TrueBlue's Gains from Investment Securities in the last 5 years was 17706.05% (2021), contrasted with its biggest fall of 8370.43% (2021).
  • TrueBlue's Gains from Investment Securities (Quarter) stood at $4.2 million in 2021, then fell by 1.15% to $4.1 million in 2022, then decreased by 1.43% to $4.1 million in 2023, then decreased by 8.21% to $3.7 million in 2024, then dropped by 9.96% to $3.4 million in 2025.
  • Its Gains from Investment Securities was $3.4 million in Q3 2025, compared to $3.7 million in Q2 2025 and $3.6 million in Q1 2025.